ArticleCancer letters2020

Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.

Foyez Mahmud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.